How often do Compassionate Care drugs get full marketing approval... Especially DCVax with 10 years in C Care and almost NO interest at all from anyone serious. and a sketchy P3 trial...?
Well, I don't know about the other drugs w the longer timelines you mentioned but just as a general rule w CRSPR drugs, I would think that evaluating safety was a much bigger issue than you would see w DCVax-L. None of that Off-target editing that we see w CRSPR. And to my knowledge the DCVax-L administration never had a death of a Jesse Gelsinger to worry about.
News 
Market Data 
Discover 
AI
